Mankind Pharma Ltd share price logo

Mankind Pharma Ltd

NSE: MANKIND

BSE: 543904

Mid Cap

FMCG Sector

Healthcare Sector

Pharma Sector

₹2375.60

-44.80

(-1.85%)

as on

bell
The current prices are delayed by 15 mins, login to check live prices.

Tech Chart

Mankind Pharma Stock Performance

as on May 29, 2026 at 9:32 pm IST

  • Day's Low

    Day's High

    ₹2,363.20
    ₹2,468.80
    downward going graph

    0.52%

    Downside

    3.92%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    ₹1,909.70
    ₹2,716.50
    downward going graph

    19.61%

    Downside

    14.35%

    Upside

    downward going graph

Mankind Pharma share price movements today

Previous Close
₹2,420.40
Open
₹2,429.80
Volume
23.48L
Upper Circuit
₹2,662.40
Lower Circuit
₹2,178.40
Day's Low - High
₹2,363.20 - ₹2,468.80
52 Week Low - High
₹1,909.70 - ₹2,716.50

Mankind Pharma Historical Returns

1 Month Return
+ 5.74 %
3 Month Return
+ 5.79 %
1 Year Return
-3.73 %
3 Year Return
+ 75.2 %
5 Year Return
+ 67.03 %

Mankind Pharma Fundamentals

as on May 29, 2026 at 4:02 pm IST

Market Cap

₹73,528.47 Cr

Return on Equity (ROE)

7.75

PE Ratio (TTM)

82.7

Return on capital employed (ROCE)

9.14

Industry PE ratio

46.01

Beta (LTM)

0.99

P/B Ratio

7.25

Dividend Yield

0.2

PEG Ratio

8.42

Quarterly Earnings Growth YOY

31.74

EPS (TTM)

6.57

Book Value

347.37

Mankind Pharma Stock Valuation

as on May 29, 2026 at 4:02 pm IST

Mankind Pharma in the last 5 years

  • Overview

  • Trends

Lowest (40.63x)

August 5, 2024

Industry (46.01x)

May 29, 2026

Today (51.25x)

May 29, 2026

Highest (58.15x)

October 7, 2025

LowHigh

Today’s Price to Earnings Ratio: 51.25x

Mankind Pharma Technical Analysis

Track how Mankind Pharma technical analysis has moved over time to understand its trends.

1 min
5 min
15 min
30 min
1 day
1 week
1 month

Technicals Summary

Bearish

Neutral

Bullish

Bearish

Moving Averages

Bearish

Neutral

Bullish

Bearish

Oscillators

Bearish

Neutral

Bullish

Bullish

Overall

Bearish8
Bullish6
Neutral1

Oscillators

Name

Value

Action

MACD level (12,26)
-3.58
Bullish
CCI (20)
523.96
Bearish
RSI (14)
47.41
Neutral
Momentum (10)
6.4
Bullish
ADI (14)
38.59
Bullish
Ultimate Oscillator (7,14,28)
23.89
Bearish

Moving Averages

Name

Value

Action

SMA (20)
2371.53
Bullish
EMA (20)
2375.41
Bullish
VWMA (20)
2372.26
Bullish
SMA (50)
2388.74
Bearish
EMA (50)
2383.94
Bearish
SMA (200)
2400.93
Bearish
EMA (200)
2400.01
Bearish
KAMA (200)
2377.96
Bearish
DEMA (200)
2386.71
Bearish

Mankind Pharma Ltd vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Mankind Pharma with its industry peers.

Company
Analyst View
Market Cap(in ₹ Cr)
5 Year CAGRDebt to Asset Ratio
Net Profit(in ₹ Cr)
Yearly Revenue(in ₹ Cr)
Laurus Labs Ltd image
Laurus Labs Ltd
HOLD73,528.4732.01%0.713545,553
Dr Reddys Laboratories Ltd image
Dr Reddys Laboratories Ltd
HOLD1,08,797.544.55%0.575,72532,643
Ajanta Pharma Ltd image
Ajanta Pharma Ltd
BUY36,592.4025.75%0.529204,648
Biocon Ltd image
Biocon Ltd
BUY69,480.212.08%0.781,42915,261
Abbott India Ltd image
Abbott India Ltd
BUY57,066.8813.51%0.001,4146,445
See all

Market expectation of Mankind Pharma Stock

Common consensus of the market based on various publicly available news, publications,brokerage expectation and market data

BUY

64.71%

Buy

17.65%

Hold

17.65%

Sell

Mankind Pharma Stock’s Investor Sentiment and Interest

Investment in Mankind Pharma Ltd Shares on INDmoney has grown by 124.68% over the past 30 days, indicating increased transactional activity.

Time period: to

Change:124.68% versus previous 30 day period

Search interest for Mankind Pharma Ltd Stock has increased by 71% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:71% versus previous 30 day period

Mankind Pharma Ltd Quarterly Profit & Loss

Figures in Rupees Crores

Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Sales
2,578.62
2,708.1
2,606.95
2,422.24
2,867.85
3,061.43
3,198.79
3,079.37
3,570.35
3,697.16
3,567.2
3,442.93
Other Income
63.35
63.45
74.73
94.56
107.9
111.63
87.09
253.65
83.05
94.19
75.96
117.28
Total Income
2,641.97
2,771.55
2,681.68
2,516.8
2,975.75
3,173.06
3,285.88
3,333.02
3,653.4
3,791.35
3,643.16
3,560.21
Expenses
1,923.81
2,025.45
2,000.45
1,836.27
2,196.29
2,216.61
2,382.8
2,400.52
2,723.58
2,775.83
2,754.36
2,536.21
Operating Profit
654.81
682.65
606.5
585.97
671.56
844.82
815.99
678.85
846.77
921.33
812.84
906.72
Operating Profit Margin %
25.39%
25.21%
23.26%
24.19%
23.42%
27.6%
25.51%
22.05%
23.72%
24.92%
22.79%
26.34%
Profit Before Interest, Tax and Depreciation
718.16
746.1
681.23
680.53
779.46
956.45
903.08
932.5
929.82
1,015.52
888.8
1,024
Interest
6.34
8.62
9.19
9.17
10.84
7.1
220.93
190.54
170.65
169.68
157.2
141.75
Depreciation
87.35
96.49
109.72
99.78
102.69
100.49
187.17
230.87
218.68
221.82
222.6
223.08
Profit Before Tax
624.47
640.99
562.32
571.58
665.93
848.86
494.98
511.09
540.49
624.02
509
659.17
Tax Paid
130.28
129.81
102.51
94.99
122.86
189.98
110.46
86.44
95.87
103.84
95.12
99.75
Profit After Tax
494.19
511.18
459.81
476.59
543.07
658.88
384.52
424.65
444.62
520.18
413.88
559.42
Total Net profit including share of profit / Loss from associate company
494.19
511.18
459.81
476.59
543.07
658.88
384.52
424.65
444.62
520.18
413.88
559.42
EPS
12.15
12.51
11.33
11.76
13.39
16.31
9.46
10.19
10.62
12.39
9.9
13.44
Actual EPS
12.15
12.51
11.33
11.76
13.39
16.31
9.46
10.19
10.62
12.39
9.9
13.44
Adjusted EPS
12.15
12.51
11.33
11.76
13.39
16.31
9.46
10.19
10.62
12.39
9.9
13.44
Diluted EPS
12.14
12.49
11.31
11.74
13.37
16.28
9.44
10.18
10.6
12.38
9.89
13.41

Mankind Pharma Ltd Annual Profit & Loss

Figures in Rupees Crores

Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Mar 2026
Sales
5,865.23
6,214.43
7,781.56
8,749.43
10,260.44
12,207.44
14,277.64
Other Income
121.96
182.63
210.48
140.99
296.41
553.56
370.48
Total Income
5,987.19
6,397.06
7,992.03
8,890.42
10,556.85
12,761
14,648.12
Expenses
4,428.42
4,566.33
5,792.2
6,848.8
7,746.76
9,189.51
10,789.98
Operating Profit
1,436.81
1,648.1
1,989.36
1,900.63
2,513.68
3,017.93
3,487.66
Operating Profit Margin %
24.5%
26.52%
25.57%
21.72%
24.5%
24.72%
24.43%
Profit Before Interest, Tax and Depreciation
1,558.77
1,830.73
2,199.83
2,041.63
2,810.09
3,571.49
3,858.14
Interest
21.97
20.15
58.61
44.47
32.75
429.41
639.28
Depreciation
99.06
118.97
166.62
325.92
378.42
621.22
886.18
Profit Before Tax
1,437.74
1,691.61
1,974.6
1,671.24
2,398.92
2,520.86
2,332.68
Tax Paid
381.59
398.58
521.64
361.57
457.15
509.74
394.58
Profit After Tax
1,056.15
1,293.03
1,452.96
1,309.68
1,941.77
2,011.12
1,938.1
Total Net profit including share of profit / Loss from associate company
1,056.15
1,293.03
1,452.96
1,309.68
1,941.77
2,011.12
1,938.1
EPS
26.36
32.28
35.78
32
47.75
49.28
46.35
Actual EPS
26.36
32.28
35.78
32
47.75
49.28
46.35
Adjusted EPS
26.36
32.28
35.78
32
47.75
49.28
46.35
Diluted EPS
26.36
32.28
35.78
32
47.68
49.19
46.28

Mankind Pharma Ltd Cash Flow

Figures in Rupees Crores

Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Net Cash from Operating Activities
1,069.71
1,137.24
919.78
1,813.3
2,152.44
2,413.38
Cash Flow from Investing Activities
-435.54
-1,221.85
-1,368.67
-1,051.82
-2,080.52
-12,624.07
Cash Flow from Financing Activities
-530.74
-7.81
604.62
-739.72
5.27
10,232.56
Net Cash Flow
103.42
-92.4
155.73
21.76
77.19
21.87

Mankind Pharma Stock Shareholding Pattern

Numbers in percentages

Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Promoters
76.5%
76.5%
76.5%
74.88%
74.87%
74.87%
72.71%
72.7%
72.68%
72.67%
72.66%
72.66%
DII
4.64%
4.39%
9.49%
11.14%
9.95%
9.9%
11.06%
11.48%
11.5%
11.92%
13.25%
14.46%
FII
0%
0%
0%
9.87%
11.58%
12.37%
13.34%
12.92%
13.07%
12.84%
11.34%
10.24%
Public
14.68%
14.76%
6.97%
4.11%
3.61%
2.86%
2.9%
2.9%
2.75%
2.57%
2.75%
2.64%
Total Outstanding Shares
40,05,88,440
40,05,88,440
40,05,88,440
40,05,88,440
40,06,35,138
40,06,44,138
41,25,66,899
41,25,78,527
41,27,28,748
41,27,58,490
41,28,05,072
41,28,28,328
Total Shareholders
1,31,918
1,34,731
1,27,449
1,35,116
1,53,450
1,63,854
1,71,281
1,80,597
1,79,549
1,70,347
1,77,539
1,77,606

Mutual Funds that own Mankind Pharma Stock

Check out the Mutual Funds with significant holdings in Mankind Pharma.

Mankind Pharma Corporate Actions

View detailed summary of the earnings and dividend history of Mankind Pharma.

  • Mankind Pharma Ltd Earnings Results

    Mankind Pharma Ltd’s net profit jumped 31.75% since last year same period to ₹554.35Cr in the Q4 2025-2026. On a quarterly growth basis, Mankind Pharma Ltd has generated 35.62% jump in its net profits since last 3-months.

    Read More about Earnings Results

  • Mankind Pharma Ltd Dividends July,2025

    In the quarter ending June 2025, Mankind Pharma Ltd has declared dividend of ₹1.00 per share on 31 Jul 2025 - translating a dividend yield of 0.04%.

    Read More about Dividends

Indices Featuring Mankind Pharma Stock

Check stock indices that include Mankind Pharma.

Nifty Healthcare

₹15,392.75

-1.86 (▲291.20%)

NIFTY PHARMA

₹24,345.80

-1.50 (▲370.20%)

S&P BSE 250 LargeMidCap

₹10,502.67

-1.43 (▲152.09%)

S&P BSE 100 LargeCap TMC

₹8,872.29

-1.47 (▲132.78%)

BSE 500

₹35,417.64

-1.34 (▲481.52%)

BSE Healthcare

₹46,806.42

-1.41 (▲667.13%)

Nifty Midcap 100

₹61,723.80

-1.33 (▲835.05%)

Nifty LargeMidcap 250

₹16,304.65

-1.41 (▲233.05%)

Nifty Midcap 50

₹17,490.55

-1.49 (▲264.40%)

BSE 200

₹11,035.46

-1.39 (▲156.05%)

Nifty 500

₹22,657.00

-1.35 (▲310.40%)

Nifty Midcap 150

₹22,571.40

-1.37 (▲313.50%)

Nifty MidSmallcap 400

₹20,515.85

-1.13 (▲234.65%)

Nifty 200

₹13,663.70

-1.43 (▲197.90%)

Insights on Mankind Pharma Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 2 quarters, 408.75 Cr → 554.35 Cr (in ₹), with an average increase of 26.3% per quarter

  • imgPOSITIVE IMPACT

    MF Holding Up

    img

    Mutual Funds have increased holdings from 9.30% to 10.36% in Mar 2026 quarter

  • imgNO EFFECT

    Promoter Holding Unchanged

    img

    Promoters holdings remained unchanged at 72.66% of holdings in Mar 2026 quarter

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 7 days, MANKIND stock has moved down by -2.4%

  • imgNEGATIVE IMPACT

    FII Holding Down

    img

    Foreign Institutions have decreased holdings from 11.34% to 10.24% in Mar 2026 quarter

  • imgNEGATIVE IMPACT

    Revenue Fall

    img

    Revenue is down for the last 3 quarters, 3.79K Cr → 3.56K Cr (in ₹), with an average decrease of 3.1% per quarter

  • imgNEGATIVE IMPACT

    Retail Holding Down

    img

    Retail Investor have decreased holdings from 2.75% to 2.64% in Mar 2026 quarter

Mankind Pharma Stock Futures & Options Contracts

View the latest movement in Mankind Pharma Futures & Options, including strike prices, expiry dates, and percentage changes.

Mankind Pharma Options

Name
Expiry
Strike Price
LTP
Absolute Change
Change
MANKIND 30 Jun ₹2500 Call
June 30, 2026
₹2500
₹45.5
-12.1
-21.01%
MANKIND 30 Jun ₹2460 Call
June 30, 2026
₹2460
₹65
-8.7
-11.8%
MANKIND 30 Jun ₹2600 Call
June 30, 2026
₹2600
₹27
-2.75
-9.24%
MANKIND 30 Jun ₹2400 Call
June 30, 2026
₹2400
₹85.4
-18.3
-17.65%

Mankind Pharma Futures

Name
Expiry
Strike Price
LTP
Absolute Change
Change
MANKIND 30 Jun Fut
June 30, 2026
-
₹2427.6
-8.77
-0.36%
MANKIND 28 Jul Fut
July 28, 2026
-
₹2421.1
-22.97
-0.94%
MANKIND 25 Aug Fut
August 25, 2026
-
₹2433.7
-11.49
-0.47%

About Mankind Pharma Ltd

Mankind Pharma Ltd. was established in 1991 as a Private Limited Company. In 2005 it was converted to a Public Limited Company and the name changed to Mankind Pharma Limited. The Company is engaged in the development, manufacturing and marketing of a range of pharmaceuticals and consumer healthcare products, and is active in acute and chronic therapeutic areas such as anti-infectives, cardiovascular and gastrointestinal treatments, antidiabetic and neuro/CNS medicines, vitamins, minerals and nutrients. In 2004, they entered the chronic pharmaceutical segment, and have added further products over the years, including ophthalmic products, consumer healthcare products, animal healthcare products and specialty therapeutic divisions. They operate 23 manufacturing facilities across India and had 2181 manufacturing personnel as of March 31, 2021. It is now planning to raise capital through the public offering of 40058844 equity shares, with a total installed capacity of 40.77 billion units across a range of products.

Revenue: ₹3,442.93Cr as on March 2026 (Q4 FY26)
Net Profit: ₹559.42Cr as on March 2026 (Q4 FY26)
Listing date: 09 May, 2023
Chairperson Name: RAMESH CHAND JUNEJA
OrganisationMankind Pharma Ltd
HeadquartersNew Delhi
IndustryPharmaceuticals
CEORAMESH CHAND JUNEJA
E-voting on sharesClick here to vote

FAQs

What is Mankind Pharma share price today?

Mankind Pharma share price today stands at ₹2375.6 as on at the close of the market. Mankind Pharma share today touched a day high of ₹2468.8 and a low of ₹2363.2.

What is the 52 week high and 52 week low range for Mankind Pharma share?

Mankind Pharma touched a 52 week high of ₹2716.5 and a 52 week low of ₹1909.7. Mankind Pharma share price today i.e. is closed at ₹2375.6, which is -12.55% down from its 52 week high and 24.40% up from its 52 week low.

What is Mankind Pharma's market capitalisation today?

Mankind Pharma market capitalisation is ₹98,090.71 Cr as on .

How to buy Mankind Pharma shares?

To buy Mankind Pharma shares, you need to follow these steps:

  • Open a Demat account and Trading account on INDmoney
  • Fund your Trading account
  • Search for MANKIND or Mankind Pharma Ltd on the INDmoney app to check live prices of the stock
  • Click on Buy or SIP to place an order to invest in Mankind Pharma shares. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.

What is Mankind Pharma trading volume today?

Mankind Pharma trading volume is 23.48L as on . This means that 23.48L shares of Mankind Pharma were bought and sold on the stock market during today's trading session.